Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 2
2008 4
2010 4
2011 1
2012 2
2013 2
2014 1
2015 2
2016 2
2017 1
2018 2
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

26 results
Results by year
Filters applied: . Clear all
Page 1
Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR-Mutant NSCLC.
Le X, Puri S, Negrao MV, Nilsson MB, Robichaux J, Boyle T, Hicks JK, Lovinger KL, Roarty E, Rinsurongkawong W, Tang M, Sun H, Elamin Y, Lacerda LC, Lewis J, Roth JA, Swisher SG, Lee JJ, William WN Jr, Glisson BS, Zhang J, Papadimitrakopoulou VA, Gray JE, Heymach JV. Le X, et al. Among authors: lacerda lc. Clin Cancer Res. 2018 Dec 15;24(24):6195-6203. doi: 10.1158/1078-0432.CCR-18-1542. Epub 2018 Sep 18. Clin Cancer Res. 2018. PMID: 30228210 Free PMC article.
miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer.
Debeb BG, Lacerda L, Anfossi S, Diagaradjane P, Chu K, Bambhroliya A, Huo L, Wei C, Larson RA, Wolfe AR, Xu W, Smith DL, Li L, Ivan C, Allen PK, Wu W, Calin GA, Krishnamurthy S, Zhang XH, Buchholz TA, Ueno NT, Reuben JM, Woodward WA. Debeb BG, et al. Among authors: lacerda l. J Natl Cancer Inst. 2016 Apr 13;108(8):djw026. doi: 10.1093/jnci/djw026. Print 2016 Aug. J Natl Cancer Inst. 2016. PMID: 27075851 Free PMC article.
Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non-small-cell Lung Cancer (NSCLC).
Elamin YY, Gomez DR, Antonoff MB, Robichaux JP, Tran H, Shorter MK, Bohac JM, Negrao MV, Le X, Rinsurogkawong W, Lewis J, Lacerda L, Roarty EB, Swisher SG, Roth JA, Zhang J, Papadimitrakopoulou V, Heymach JV. Elamin YY, et al. Among authors: lacerda l. Clin Lung Cancer. 2019 Jan;20(1):43-47. doi: 10.1016/j.cllc.2018.09.015. Epub 2018 Sep 24. Clin Lung Cancer. 2019. PMID: 30343004
Response rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer.
Schvartsman G, Peng SA, Bis G, Lee JJ, Benveniste MFK, Zhang J, Roarty EB, Lacerda L, Swisher S, Heymach JV, Fossella FV, William WN. Schvartsman G, et al. Among authors: lacerda l. Lung Cancer. 2017 Oct;112:90-95. doi: 10.1016/j.lungcan.2017.07.034. Epub 2017 Aug 3. Lung Cancer. 2017. PMID: 29191606
Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a.
Wolfe AR, Debeb BG, Lacerda L, Larson R, Bambhroliya A, Huang X, Bertucci F, Finetti P, Birnbaum D, Van Laere S, Diagaradjan P, Ruffell B, Trenton NJ, Chu K, Hittelman W, Diehl M, Levental I, Ueno NT, Woodward WA. Wolfe AR, et al. Among authors: lacerda l. Breast Cancer Res Treat. 2015 Dec;154(3):495-508. doi: 10.1007/s10549-015-3645-3. Epub 2015 Nov 21. Breast Cancer Res Treat. 2015. PMID: 26590814 Free PMC article.
Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model.
Lacerda L, Debeb BG, Smith D, Larson R, Solley T, Xu W, Krishnamurthy S, Gong Y, Levy LB, Buchholz T, Ueno NT, Klopp A, Woodward WA. Lacerda L, et al. Breast Cancer Res. 2015 Mar 20;17(1):42. doi: 10.1186/s13058-015-0549-4. Breast Cancer Res. 2015. PMID: 25887413 Free PMC article.
Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism.
Debeb BG, Lacerda L, Larson R, Wolfe AR, Krishnamurthy S, Reuben JM, Ueno NT, Gilcrease M, Woodward WA. Debeb BG, et al. Among authors: lacerda l. Oncotarget. 2016 May 10;7(19):28329-39. doi: 10.18632/oncotarget.8631. Oncotarget. 2016. PMID: 27078845 Free PMC article.
Carbon nanotubes as nanomedicines: from toxicology to pharmacology.
Lacerda L, Bianco A, Prato M, Kostarelos K. Lacerda L, et al. Adv Drug Deliv Rev. 2006 Dec 1;58(14):1460-70. doi: 10.1016/j.addr.2006.09.015. Epub 2006 Sep 30. Adv Drug Deliv Rev. 2006. PMID: 17113677 Review.
Potential targets for improving radiosensitivity of breast tumor-initiating cells.
Xu W, Debeb BG, Lacerda L, Woodward WA. Xu W, et al. Among authors: lacerda l. Anticancer Agents Med Chem. 2010 Feb;10(2):152-6. doi: 10.2174/187152010790909362. Anticancer Agents Med Chem. 2010. PMID: 20184537 Review.
Detection of Glioblastoma Subclinical Recurrence Using Serial Diffusion Tensor Imaging.
Jin Y, Randall JW, Elhalawani H, Feghali KAA, Elliott AM, Anderson BM, Lacerda L, Tran BL, Mohamed AS, Brock KK, Fuller CD, Chung C. Jin Y, et al. Among authors: lacerda l. Cancers (Basel). 2020 Feb 29;12(3):568. doi: 10.3390/cancers12030568. Cancers (Basel). 2020. PMID: 32121471 Free PMC article.
26 results
Jump to page
Feedback